A Phase I Study to Evaluate the Safety and Pharmacokinetics of TRN501 in Healthy Adult Japanese Male Volunteers
Latest Information Update: 13 Jun 2024
At a glance
- Drugs TRN 501 (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors SNLD
Most Recent Events
- 13 Jun 2024 New trial record